Analyst consensus rating
Innate Pharma S.A. - American Depositary Shares Analyst Consensus Rating
IPHA analyst consensus rating, coverage count and price target evidence.
Direct answer
Innate Pharma S.A. - American Depositary Shares's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.50.
Forecast evidence checked August 12, 2026.
Get free Innate Pharma S.A. - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.47
- Average price target
- $6.50
- High price target
- $8.00
- Low price target
- $3.00
- Target upside
- +163.2%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026